Skip to content

Niemann Pick Disease Type D C0268247

Published: July 22, 2026Updated: August 20, 2026

A rare lysosomal storage disorder affecting the nervous system, causing progressive neurological decline. Primarily impacts children and currently has limited treatments, focusing on symptom management and supportive care.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Seizures

Fatigue or weight changes

(metabolic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Cognitive decline

(neurological)

Vertical supranuclear gaze palsy

(neurological)

Cataplexy

(neurological)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Miglustat therapy

Substrate reduction therapy targeting the underlying glycolipid accumulation defect in Niemann-Pick type D, slowing neurological deterioration when initiated early.

medication
3

Ophthalmological surveillance

Regular vertical supranuclear gaze palsy assessment and visual function testing to monitor disease progression and guide management decisions.

monitoring

Additional treatment options

Surgical intervention for splenomegaly

Partial splenectomy or other surgical approaches to manage severe splenomegaly causing discomfort, cytopenias, or risk of rupture.

surgical

Caloric and metabolic supplementation

Enhanced nutritional support with attention to metabolic demands, often including protein supplementation to prevent cachexia.

dietary

Integrative supportive care

Complementary approaches including massage therapy and acupuncture for symptom management, particularly for pain and spasticity associated with neurological decline.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Niemann Pick Disease Type D C0268247?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Niemann Pick Disease Type D C0268247. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy